Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer

N Engl J Med. 1999 May 6;340(18):1439. doi: 10.1056/NEJM199905063401814.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Androgen Antagonists / therapeutic use
  • Cyproterone Acetate / therapeutic use
  • Drug Implants
  • Drug Therapy, Combination
  • Flutamide / therapeutic use
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Humans
  • Luteinizing Hormone / blood
  • Male
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy*
  • Testosterone / blood

Substances

  • Androgen Antagonists
  • Drug Implants
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Cyproterone Acetate
  • Flutamide
  • Luteinizing Hormone
  • Prostate-Specific Antigen
  • histrelin